Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sexual Dysfunction in Women With Multiple Sclerosis: Dimensions and Contributory Factors



Ashtari F1 ; Rezvani R1 ; Afshar H2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Isfahan University of Medical Sciences, Ayatolah Kashani Hospital, Isfahan, Iran
  2. 2. Department of Psychiatric, Isfahan University of Medical Sciences, Ayatolah Kashani Hospital, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2014

Abstract

Background: Sexual dysfunction (SD) is a common reported problem in patients with multiple sclerosis (MS). Aims: to examine frequency and distribution of SD dimensions and to determine whether SD is related to various clinical and demographic variables in female patients. Materials and Methods: A total of 271 MS women (age: 19-50 years) participated in this cross-sectional study. We used a structured demographic and clinical interview and Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Disability was rated by Expanded Disability Status Score (EDSS). Results: 63.5% (n = 173) of women had SD included 142 (52.4%) women with primary SD, 102 (37.5%) women with secondary SD and 120 (41%) women with tertiary SD. Th e most common SDrelated complaint was orgasmic problem (41.2%). Women with primary SD were significantly older and had higher EDSS score. No significant relationship was found between primary SD and disease duration. Fatigue (OR = 2.69, 95% CI: 1.352-5.385, P = 0.005), memory and concentration complaints (OR = 1.915, 95% CI: 1.034-3.546, P = 0.039) and some of urinary symptoms such as frequency (OR = 2.108, 95% CI: 1.015-4.375, P = 0.045) were seem to be the significant predictors. Fatigue was also found to be the most powerful predicting factor for tertiary SD (OR = 2.793, 95% CI: 1.358-5.744 P = 0.005). Conclusion: SD, a common multifactorial problem among MS women, can arise at any time during the disease and with any level of disability. However, we found relationships between SD and some of clinical variables and symptoms. Understanding these relationships would help us to develop practical approach and treatment for SD.
Related Docs
View other Related Docs
1. Prevalence and Risk of Developing Sexual Dysfunction in Women With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, BMC Women's Health (2023)
2. The Prevalence of Sexual Dysfunction and Erectile Dysfunction in Men With Multiple Sclerosis: A Systematic Review and Meta-Analysis; [La Prevalencia De La Disfuncion Sexual Y La Disfuncion Erectil En Hombres Con Esclerosis Multiple: Una Revision Sistematica Y Metanalisis], Neurologia (2025)
3. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
4. Prevalence of Sexual Dysfunction and Related Risk Factors in Men With Multiple Sclerosis in Iran: A Multicenter Study, Neurology and Therapy (2021)
5. Sexual Function and Related Predictors in Male With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Journal of Sexual Medicine (2025)
6. Sexual Dysfunction in Women With Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis, Sexuality and Disability (2022)
7. Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)
8. The Effect of Counseling Based on the Plissit Model on Sexual Quality of Life of Married Women With Multiple Sclerosis Referring to Ms Center in 2019: A Randomized, Controlled Trial, Archives of Women's Mental Health (2021)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (92)
Masoud Etemadifar (68)
Other Related Docs
9. The Prevalence of Lower Urinary Tract Symptoms Based on Individual and Clinical Parameters in Patients With Multiple Sclerosis, BMC Neurology (2020)
10. Sex As a Determinant of Relapse Incidence and Progressive Course of Multiple Sclerosis, Brain (2013)
11. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
12. Effects of Resistance Training and Vibration on Hormonal Changes in Female Patients With Multiple Sclerosis, Neurology Asia (2014)
13. Risk Factors of Early Onset of Ms in Women in Reproductive Age Period: Survival Analysis Approach, Archives of Women's Mental Health (2016)
14. Male Sex Is Independently Associated With Faster Disability Accumulation in Relapse-Onset Ms But Not in Primary Progressive Ms, PLoS ONE (2015)
15. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
16. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
17. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
18. Confirmed Disability Progression As a Marker of Permanent Disability in Multiple Sclerosis, European Journal of Neurology (2022)
19. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
20. Study of Type a and B Behavior Patterns in Patients With Multiple Sclerosis in an Iranian Population, International Journal of Preventive Medicine (2013)
21. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
22. Emotional Competencies in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
23. Mri Features and Disability in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2024)
24. Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy, European Neurology (2012)
25. Variability of the Response to Immunotherapy Among Subgroups of Patients With Multiple Sclerosis, European Journal of Neurology (2023)
26. Increasing Female Preponderance of Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2010)
27. Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis Compared to Healthy Adolescents and Young Adults, Neuropsychiatric Disease and Treatment (2016)
28. Evaluating Sex Hormone Levels in Reproductive Age Women With Multiple Sclerosis and Their Relationship With Disease Severity, Journal of Research in Medical Sciences (2012)
29. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
30. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
31. Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis, Journal of Education and Health Promotion (2021)
32. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province, International Journal of Preventive Medicine (2016)
33. Fatigue, Depression, and Health-Related Quality of Life in Patients With Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2012)
34. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
35. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis, Neurotherapeutics (2025)
36. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)
37. Stress Differentially Predicts Multiple Sclerosis Relapses, Neurology Asia (2014)
38. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
39. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years, Neurology (2021)
40. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
41. Contribution of Different Relapse Phenotypes to Disability in Multiple Sclerosis, Multiple Sclerosis (2017)
42. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis, JAMA Neurology (2018)
43. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
44. Comparing the Effects of Reflexology and Relaxation on Fatigue in Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2015)
45. Working Memory Dysfunction Differs Between Secondary Progressive and Relapsing Multiple Sclerosis: Effects of Clinical Phenotype, Age, Disease Duration, and Disability, Multiple Sclerosis and Related Disorders (2023)
46. Barriers to Quality of Life in Patients With Multiple Sclerosis: A Qualitative Study, BMC Neurology (2022)
47. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, JAMA - Journal of the American Medical Association (2019)
48. The Global Prevalence of Familial Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis, BMC Neurology (2021)
49. Prevalence of Cognitive Impairment (Ci) in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Caspian Journal of Internal Medicine (2024)
50. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)